EASL Clinical Practice Guidelines: management of chronic hepatitis B
European Association For The Study Of The Liver - Journal of hepatology, 2009 - Elsevier
Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease has improved. Several new and effective antiviral agents
have been evaluated and licensed since the EASL International Consensus Conference on
hepatitis B held in 2002 [1]. The objective of these EASL Clinical Practice Guidelines (CPGs)
is to update recommendations for the optimal management of chronic hepatitis B (CHB). The
CPGs do not focus on prevention and vaccination. Several difficulties remain in formulating …
for therapy of the resultant disease has improved. Several new and effective antiviral agents
have been evaluated and licensed since the EASL International Consensus Conference on
hepatitis B held in 2002 [1]. The objective of these EASL Clinical Practice Guidelines (CPGs)
is to update recommendations for the optimal management of chronic hepatitis B (CHB). The
CPGs do not focus on prevention and vaccination. Several difficulties remain in formulating …